Search details
1.
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
PLoS Biol
; 20(7): e3001709, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35788562
2.
Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss HIV Cohort Study.
J Infect Dis
; 2024 Jan 16.
Article
in English
| MEDLINE | ID: mdl-38227786
3.
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3).
J Infect Dis
; 2024 Jun 07.
Article
in English
| MEDLINE | ID: mdl-38848312
4.
Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID-19 prevention.
Br J Haematol
; 204(5): 1908-1912, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38327109
5.
Impact of hormonal therapy on HIV-1 immune markers in cis women and gender minorities.
HIV Med
; 2024 Jun 03.
Article
in English
| MEDLINE | ID: mdl-38830635
6.
Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity.
J Infect Dis
; 228(8): 1042-1054, 2023 10 18.
Article
in English
| MEDLINE | ID: mdl-37261930
7.
Alpha Variant Coronavirus Outbreak in a Nursing Home Despite High Vaccination Coverage: Molecular, Epidemiological, and Immunological Studies.
Clin Infect Dis
; 77(4): 537-546, 2023 08 22.
Article
in English
| MEDLINE | ID: mdl-35522980
8.
Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation.
Br J Haematol
; 201(1): 58-63, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36382698
9.
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.
Clin Infect Dis
; 75(1): e585-e593, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-35234868
10.
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS).
HIV Med
; 23(4): 417-425, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35194949
11.
Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report.
BMC Infect Dis
; 21(1): 298, 2021 Mar 24.
Article
in English
| MEDLINE | ID: mdl-33761897
12.
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients.
Clin Infect Dis
; 70(2): 297-303, 2020 01 02.
Article
in English
| MEDLINE | ID: mdl-30843028
13.
Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series.
Stroke
; 51(12): 3719-3722, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33054673
14.
B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma.
Br J Haematol
; 2024 May 23.
Article
in English
| MEDLINE | ID: mdl-38782604
15.
A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature.
Transpl Infect Dis
; 20(1)2018 Feb.
Article
in English
| MEDLINE | ID: mdl-29044831
16.
Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.
PLoS Pathog
; 8(4): e1002634, 2012.
Article
in English
| MEDLINE | ID: mdl-22496655
17.
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1.
AIDS
; 38(2): 217-222, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-37830908
18.
Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome.
Open Forum Infect Dis
; 11(1): ofad641, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38179103
19.
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
mBio
; 15(2): e0272223, 2024 Feb 14.
Article
in English
| MEDLINE | ID: mdl-38270455
20.
Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022.
Swiss Med Wkly
; 153: 3502, 2023 Dec 22.
Article
in English
| MEDLINE | ID: mdl-38579325